1

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer

sjqckna7cqnbp
Abstract Background Lung cancer is a malignant carcinoma which has the highest morbidity and mortality in Chinese population. Gefitinib. a tyrosine kinase (TK) inhibitor of epidermal growth factor receptor (EGFR). displays anti-tumor activity. https://www.goodvibesbadhabiters.shop/product-category/silicone-lube/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story